首页|医疗机构新型抗肿瘤药物临床应用管理模式探讨

医疗机构新型抗肿瘤药物临床应用管理模式探讨

扫码查看
目的:探讨医疗机构对新型抗肿瘤药物临床应用的管理模式。方法:依据国家药事法律法规和《抗肿瘤药物临床应用管理办法(试行)》等相关要求,结合医疗机构新型抗肿瘤药物临床使用实际需求,论述医疗机构对新型抗肿瘤药物临床应用管理的模式。结果:医疗机构可围绕药品遴选、药品供应、处方审核和点评、静脉用药配置、临床使用、监测评价等核心内容,结合本院实际工作,对抗肿瘤药物进行全程化用药管理。结论:新型抗肿瘤药物上市时间短,其有效性、安全性有待进一步验证,临床应用管理十分重要,应以患者为中心,以临床需求为导向,对抗肿瘤药物临床使用进行全程化管理及监测,确保临床用药安全、有效、经济、适宜。
Exploration on Management Mode of Clinical Application of New Anti-Tumor Drugs in Medical Institutions
OBJECTIVE:To explore the management mode of clinical application of new anti-tumor drugs in medical institutions.METHODS:According to the relevant requirements of national pharmaceutical regulations and the Administration Measures for Clinical Application of Anti-Tumor Drugs(Trial),this paper discussed management mode of the clinical application of new anti-tumor drugs combined with the actual needs of clinical application of new anti-tumor drugs in medical institutions.RESULTS:Medical institutions could conduct whole-process medication management on anti-tumor drugs in combination with actual work focus on drug selection,drug supply,prescription review and comment,intravenous drug allocation,clinical application,monitoring and evaluation.CONCLUSIONS:New anti-tumor drugs have been on the market for a short period of time,its efficacy and safety need to be further verified,clinical application management is very important,the whole-process management and monitoring on the clinical application of anti-tumor drugs should be conducted patient-centered and oriented to clinical needs,so as to ensure the safety,effectiveness,economical efficiency and appropriation of clinical medication.

New anti-tumor drugsPharmaceutical administrationPrescription review

李莹、刘敏、乐凯迪、闫加庆、戴媛媛、李国辉

展开 >

国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021

新型抗肿瘤药物 药事管理 处方审核

首都卫生发展科研专项资助项目

首发2022-2-4028

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(2)
  • 22